Nyxol Posts 5 Positive Clinical Data Readouts Including Presbyopia in Last 12 Months
Successfully Enrolled 4 Late-Stage Trials for Nyxol and APX3330 in First Quarter
Read more at globenewswire.comAll information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here
Nyxol Posts 5 Positive Clinical Data Readouts Including Presbyopia in Last 12 Months
Successfully Enrolled 4 Late-Stage Trials for Nyxol and APX3330 in First Quarter
Read more at globenewswire.com| Symbol | Last | Chg | %Chg |
|---|---|---|---|
| OCUP | 1.1700 | -0.1600 | -12.03% |
| Ocuphire Pharma Inc | |||